NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Doximity Inc. (NYSE: DOCS)
DOCS Technical Analysis
5
As on 7th Feb 2025 DOCS SHARE Price closed @ 79.23 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 25.79 & Strong Buy for SHORT-TERM with Stoploss of 21.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DOCSSHARE Price
Open | 72.50 | Change | Price | % |
High | 80.71 | 1 Day | 20.97 | 35.99 |
Low | 71.50 | 1 Week | 21.56 | 37.39 |
Close | 79.23 | 1 Month | 21.05 | 36.18 |
Volume | 10246873 | 1 Year | 55.32 | 231.37 |
52 Week High 61.25 | 52 Week Low 19.86 |
NYSE USA Most Active Stocks
FSR | 0.02 | 0.00% |
DDR | 15.44 | -4.46% |
PLTR | 110.85 | -0.39% |
TWTR | 53.70 | 0.66% |
F | 9.24 | -0.22% |
SWN | 7.11 | -0.56% |
BACA-U | 302.00 | 0.67% |
ENLC | 14.12 | -0.21% |
UBER | 74.60 | 6.59% |
BBD | 2.12 | -4.93% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
DOCS Daily Charts |
DOCS Intraday Charts |
Whats New @ Bazaartrend |
DOCS Free Analysis |
|
DOCS Important Levels Intraday
RESISTANCE | 96.98 |
RESISTANCE | 91.29 |
RESISTANCE | 87.77 |
RESISTANCE | 84.25 |
SUPPORT | 74.21 |
SUPPORT | 70.69 |
SUPPORT | 67.17 |
SUPPORT | 61.48 |
DOCS Forecast February 2025
4th UP Forecast | 88.81 |
3rd UP Forecast | 85.74 |
2nd UP Forecast | 83.84 |
1st UP Forecast | 81.94 |
1st DOWN Forecast | 76.52 |
2nd DOWN Forecast | 74.62 |
3rd DOWN Forecast | 72.72 |
4th DOWN Forecast | 69.65 |
DOCS Weekly Forecast
4th UP Forecast | 83.45 |
3rd UP Forecast | 82.10 |
2nd UP Forecast | 81.26 |
1st UP Forecast | 80.42 |
1st DOWN Forecast | 78.04 |
2nd DOWN Forecast | 77.20 |
3rd DOWN Forecast | 76.36 |
4th DOWN Forecast | 75.01 |
DOCS Forecast2025
4th UP Forecast | 196.78 |
3rd UP Forecast | 159.08 |
2nd UP Forecast | 135.78 |
1st UP Forecast | 112.48 |
1st DOWN Forecast | 45.99 |
2nd DOWN Forecast | 22.68 |
3rd DOWN Forecast | -0.62 |
4th DOWN Forecast | -38.32 |
Doximity Inc. ( NYSE USA Symbol : DOCS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DOCS Other Details
Segment | EQ | |
Market Capital | 12953963520.00 | |
Sector | Healthcare | |
Industry | Health Information Services | |
Offical website | > echo $website ; ?> |
DOCS Address
![]() |
DOCS Latest News
DOCS Business Profile
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California. Address: 500, 3rd Street, San Francisco, CA, United States, 94107
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service